Isopto Atropine Side Effects
Generic name: atropine ophthalmic
Medically reviewed by Drugs.com. Last updated on Apr 9, 2024.
Note: This document provides detailed information about Isopto Atropine Side Effects associated with atropine ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Isopto Atropine.
Applies to atropine ophthalmic: ophthalmic ointment, ophthalmic solution.
Serious side effects of Isopto Atropine
Along with its needed effects, atropine ophthalmic (the active ingredient contained in Isopto Atropine) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking atropine ophthalmic:
Incidence not known
- blurred vision
- change in color vision
- difficulty seeing at night
- eye pain or stinging
- fast, pounding, or irregular heartbeat or pulse
- increased sensitivity of the eyes to sunlight
Other side effects of Isopto Atropine
Some side effects of atropine ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
- confusion as to time, place, or person
- decreased tearing of the eyes
- drowsiness
- dry skin, mouth, or throat
- feeling of warmth
- hallucinations
- holding false beliefs that cannot be changed by fact
- irritability
- redness of the clear part of the eye
- redness of the face, neck, arms, and occasionally, upper chest
- unusual excitement, nervousness, or restlessness
For healthcare professionals
Applies to atropine ophthalmic: ophthalmic ointment, ophthalmic solution.
General adverse events
The most commonly occurring side effects include blurred vision, photophobia, eye pain and stinging, decreased lacrimation. Systemic effects are more common in infants and elderly.[Ref]
Cardiovascular
- Frequency not reported: Transient bradycardia followed by tachycardia, palpitations, and arrhythmia[Ref]
Severe reaction to the ointment may include hypotension.[Ref]
Nervous system
- Frequency not reported: Ataxia, restlessness, excitement, irritability, hyperactivity, somnolence, confusion, delirium, hallucinations[Ref]
Ocular
- Common (1% to 10%): Eye pain, stinging, blurred vision, photophobia, decreased lacrimation
- Frequency not reported: Superficial keratitis (with prolonged use), conjunctivitis, hyperemia, edema[Ref]
Gastrointestinal
Hypersensitivity
- Frequency not reported: Contact dermatitis, allergic conjunctivitis, eyelid edema[Ref]
Respiratory
- Frequency not reported: Decreased bronchial secretions with dry throat and difficulty talking[Ref]
Severe reaction to the ointment may include hypotension with progressive respiratory depression. Coma and death have been reported in very young children.[Ref]
Dermatologic
Genitourinary
- Frequency not reported: Urinary retention, urinary urgency
Local
- Frequency not reported: Local irritation (with prolonged use)
Psychiatric
- Frequency not reported: Confusion, delirium, hallucinations
References
1. (2002) "Product Information. Atropisol (atropine ophthalmic)." Ciba Vision Ophthalmics
More about Isopto Atropine (atropine ophthalmic)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Generic availability
- Drug class: mydriatics
- Breastfeeding
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Isopto Atropine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.